Transparency Market Research published new
market report "Molecular Cytogenetics Market (Technologies: FISH and
aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) -
Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 -
2019," the global molecular
cytogenetics market was valued at USD 469.2 million in 2012 and is estimated to
reach a market worth USD 1.97 billion in 2019 at a CAGR of 23.4% from 2013 to
2019.
Browse the full report at http://www.transparencymarketresearch.com/molecular-diagnostics-market.html
Molecular
cytogenetics is emerging as an indispensable tool in the field of research and
diagnosis. Until the advent of molecular cytogenetics techniques in 1980s,
chromosomal analysis was mainly based on banding patterns. Although, the
traditional banding techniques encountered problems such as low resolution and
poor quality analysis. However, breakthrough in fluorescence in situ
hybridization (FISH) and array-comparative genomic hybridization (aCGH)
techniques has enhanced the diagnosis of chromosomal anomalies particularly in
tumor and hematological malignancies. Nowadays, cytogenetics techniques are
being considered mandatory in diagnosis and prognosis of leukemia. The
techniques are considered as a standard laboratory test since they provide
global screening of abnormalities. The scope of molecular cytogenetics is
increasing with the rising cancer incidences worldwide and growing popularity
of personalized medicines.
T
he ability of
FISH technique to study cells at an interphase stage of the cell cycle has made
the technique a breakthrough in molecular cytogenetics field. FISH technique is
used in the research of diverse applications such as cancer, cardiovascular and
genetic disorder. The impetus of FISH technique is a direct result of improved
understanding of sequence, structure and function of human genome. Similarly,
supported by technological advancements in fluorescent microscopes and digital
imaging, FISH technique has emerged as a preferred tool in molecular
cytogenetics. The technique facilitates the analysis of sub-chromosomal regions
and the identifications of small translocations thereby, routinely used in clinical
applications. Owing to the techniques' sensitivity and specificity, FISH is
significantly used in number of cytogenetic and pathological laboratories.
The advent of
aCGH is ushering new standards for the analysis of genome. The technology has
turned out to be a greatest driver for the molecular cytogenetics market as it
is overcoming the resolution problems associated with traditional banding
techniques. aCGH is poised to witness a significant growth in the market and is
likely to emerge as the fastest growing technology segment. aCGH has propelled
the cytogenetics market from the microscopes to computers and thus, facilitated
simultaneous analysis of thousands of discrete regions of the genome.
Similarly, the
technique is gaining popularity as one assay performed on this technique is
comparable to thousands of FISH experiments and hence, saves time and cost.
Moreover, the technique is expected to rapidly supplant FISH technique owing to
further technological advancements in the technique. Likewise, increasing
sensitivity of the aCGH technique is preferred as a primary diagnosis tool
followed by validation with FISH. The technique is emerging as a powerful tool
for high resolution analysis of sub-microscopic chromosomal abnormalities. aCGH
is also evolving as a method of choice for molecular cytogenetics by the
researchers owing to its work flow advantages and cost effectiveness.
North America
accounts for the largest share of the molecular cytogenetics market followed by
the European region. The markets for these regions are driven by factors such
as increased level of public awareness, rising cancer incidences and large
number of research institutes engaged in cytogenetics field. However,
Asia-Pacific region is likely to emerge as the fastest growing region over the
analysis period. Cancer diagnosis is likely to witness a significant growth and
emerge as the fastest growing segment during analysis period with a CAGR of
more than 20%.
The growing
demand for molecular cytogenetics techniques in research and data
interpretation has resulted in quick expansion of manufacturers' product
portfolio. The manufacturers are focused on building aggressive strategies for
the development of innovative products that would cater research and diagnostic
sectors. The vendors are eager to tap the emerging regions and end-users of
this market. Major players engaged in development of innovative molecular
cytogenetics techniques are Abbott laboratories, Affymetrix, Inc., Applies
Spectral Imaging, BI Biological Industries, Life Technologies
Corporation,
Roche Diagnostics, Oxford Gene Technology, Illumina, Inc., among others.
The molecular
cytogenetics market is segmented as follows:
Molecular Cytogenetics Market,
by Technology
·
FISH
·
aCGH
Molecular Cytogenetics Market,
by Application
·
Genetic
Disorders
·
Cancer
·
Personalized
Medicine
·
Others
Molecular Cytogenetics Market,
by Geography
·
North
America
·
Europe
·
Asia-Pacific
·
RoW
Pharmaceutical Market Reports
Related Blogs :
TABLE OF CONTENTS (TOC Summary)
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Molecular Cytogenetics Market, by
Technology
Chapter 5 Molecular Cytogenetics Market, by
Applications
Chapter 6 Molecular Cytogenetics Market, by Geography
Chapter 7 Recommendations
Chapter 8 Company Profiles
Browse the report With Full TOC at
About Us:
Transparency
Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insight for thousands
of decision makers.
We
are privileged with highly experienced team of Analysts, Researchers and
Consultants, who use proprietary data sources and various tools and techniques
to gather, and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to sustain a
competitive edge.
